Community pharmacy training programme and guidance for supporting patients receiving oral anticancer therapy

Dear BOPA Member,
 
Please see details of a community pharmacy training programme and guidance for supporting patients receiving oral anticancer therapy. The purpose of the training programme is to provide a training template for community pharmacy to those wishing to adopt a new model of care for patients receiving oral SACT. For this programme to be effective it will need interest from both secondary care and community pharmacy stakeholders. The guidance document provides information on a model of care whereby patients are referred to community pharmacy from secondary care for extra support with their oral SACT. Both of these documents were developed during a Darzi Fellowship. They have been shared so that others wishing to set up a similar model of care can adapt these documents for relevance to their needs. Feel free to contact the author if you require any further information (Melanie Dalby, [email protected]).
 
To access the documents click here: https://www.bopa.org.uk/resources/guidance-on-the-oral-anticancer-medication-oam-review-service-by-community-pharmacy/
To access the documents click here: https://www.bopa.org.uk/resources/oral-anticancer-medication-oam-review-by-community-pharmacy-training-programme/
 
Melanie Dalby | Principal Pharmacist – Operational Lead for Cancer Services
Darzi Fellow 2016/17 | Guy’s and St Thomas’ NHS Foundation Trust

Latest News

By BOPA Executive Committee on 30th October 2026

Publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs

We are delighted to recognise the recent publication of Pharmaceutical Technology and Pharmacology of Parenteral Oncology Drugs, a new book bringing together expertise from oncology pharmacy professionals across the world.…

Read article
By BOPA Executive Committee on 30th October 2026

Acute and Supportive Oncology Clinical Consensus Statement

BOPA welcomes the Acute and Supportive Oncology Clinical Consensus Statement, to which we were pleased to contribute. It will be a benchmark for the sector, bringing direction and consistency as…

Read article
By BOPA, COSA, CAPhO & ISOPP on 13th October 2026

International Debate Webinar: Eastern and Western Medicine Can Co-exist – part of London Global Cancer Week 2026

Monday 2 November 2026 | 21:00 GMT (check your local time) Part of London Global Cancer Week 2026 Can Eastern and Western medicine co-exist in modern cancer care? Or do…

Read article
By Joseph Williams on 8th October 2026

BOPA 2026 Mentioned in Pharmaceutical Journal

Invest in aseptic services for future of specialised medicines, says chief pharmacist – The Pharmaceutical Journal Aseptic facilities are “absolutely essential” for hospitals to be involved in clinical trials and…

Read article